The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Background Closed-loop control systems of insulin delivery may improve glycemic
outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a …

Despite over 100 years of insulin therapy, glycemia remains suboptimal for many individuals
living with diabetes. Data from international diabetes registries highlight that most youth with …

Objective: To evaluate the effect of hybrid-closed loop Control-IQ technology (Control-IQ) in
randomized controlled trials (RCTs) in subgroups based on baseline characteristics such as …

Continuous glucose monitoring (CGM) technology has evolved over the past decade with
the integration of various devices including insulin pumps, connected insulin pens (CIPs) …

Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

Objective: The safety and impact of the advanced hybrid closed-loop (AHCL) system on
glycemic outcome in 2-to 6-year-old children with type 1 diabetes and the diabetes distress …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Children with type 1 diabetes and their caregivers face numerous challenges navigating the
unpredictability of this complex disease. Although the burden of managing diabetes remains …